The Company has enclosed herewith Notice of 34th AGM along with Annual Report FY 2025-26.

Krebs Biochemicals & Industries Limited CIN : L24110AP1991PLC103912 4th September 2026 To, To, BSE Limited National Stock Exchange of India Ltd P J Towers, Dalal Street, Exchange Plaza, Bandra Kurla Complex, Fort, Mumbai- 400001. Bandra(E), Mumbai- 400051. Scrip Code : 524518 Scrip Code : KREBSBIO Dear Sir/Madam, Sub: Notice of 34th Annual General Meeting of the Company We wish to inform you that the 34th Annual General Meeting (‘AGM’) of the Company will be held on Tuesday, 29th September 2026 at 11:30 a.m. through Video Conferencing / Other Audio Visual Means (VC/OAVM) to transact the business as set out in the notice convening the said Annual General Meeting which is e-mailed to the shareholders of the Company. The Annual Report 2025-26 for the financial year ended 31st March, 2026 of which the Notice of the 34th AGM is a part has been sent in electronic mode to Members whose e-mail IDs are registered with the Company or with the Depository Participant(s). The requirements of sending physical copy of the Notice of the AGM and the Annual Report to the Members have been dispensed with vide MCA / SEBI Circular(s) issued from time to time. The Annual Report for the financial year 2025-26 of which the notice of the 34th AGM is a part is available on the Company’s website www.krebsbiochem.com. Members who have not received the Annual Report may download it from the Company’s website or may request for an electronic copy of the same by writing to the Company at com_sec@krebsbiochem.com. We also wish to inform you that pursuant to the provisions of Section 108 of the Companies Act, 2013 and Rule 20 of the Companies (Management and Administration) Rules, 2014 as amended by the Companies (Management and Administration) Amendment Rules, 2015 and Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company is pleased to provide e-voting facility to members to exercise their right to vote on the agenda items as stated in the notice of the Annual General Meeting by electronic means and the business may be transacted through the e-voting services provided by KFin Technologies Limited (“KFintech”). Regd. Office : Kothapalli (V), Kasimkota (M), Anakapalli, Visakhapatnam, Andhra Pradesh-531 031 Tel : 040-66808040 Website- www.krebsbiochem.com E-mail- com_sec@krebsbiochem.com Krebs Biochemicals & Industries Limited CIN : L24110AP1991PLC103912 The details pursuant to the provisions of Section 108 of the Companies Act, 2013 and the relevant Rules prescribed thereunder are as follows: 1. The business will be transacted through voting by electronic means. 2. Date and time of commencement of remote e-voting: Friday, 25th September, 2026 (09:00 a.m.) 3. Date and time of end of remote e-voting: Monday, 28th September, 2026 (05:00 p.m.) 4. Cut-off Date: Wednesday, 23rd September, 2026. 5. Members who have acquired shares after the dispatch of Annual Report and before cut- off date may obtain user id and password by sending request at evoting@kfintech.com mentioning his/her Folio No./DP ID and Client ID No. 6. E-voting by electronic mode shall not be allowed beyond 5.00 p.m. on 28th September, 2026. 7. The members who have cast their vote by remote e-voting prior to the AGM may also attend the AGM through VC/OAVM but shall not be entitled to cast their vote again. 8. Members of the Company holding shares either in physical form or in dematerialized form as on the cut-off date of 23rd September, 2026 only shall be entitled to avail the facility of remote e-voting as well as voting at Meeting. The voting rights of the members shall be in proportion to their shares of the paid-up equity share capital of the Company. 9. The Company is also providing e-voting facility to its members in respect of the business to be transacted during the 34th AGM. Members may follow the same procedure for e-Voting during the 34th AGM as mentioned above for remote e-Voting. Only those Members, who will be present in the 34th AGM through VC/OAVM Facility and have not cast their vote on the Resolutions through remote e-Voting shall be eligible to vote through e-Voting system in the 34th AGM. 10. The Annual Report for the financial year 2025-26 of which the Notice of the 34th AGM is a part is also available on the Company’s website www.krebsbiochem.com and also hosted on the Stock Exchanges where the shares of the Company are listed, i.e., BSE Limited (www.bseindia.com) and The National Stock Exchange of India Ltd. Regd. Office : Kothapalli (V), Kasimkota (M), Anakapalli, Visakhapatnam, Andhra Pradesh-531 031 Tel : 040-66808040 Website- www.krebsbiochem.com E-mail- com_sec@krebsbiochem.com Krebs Biochemicals & Industries Limited CIN : L24110AP1991PLC103912 (www.nseindia.com) and on the website of KFin Technologies Limited https://evoting.kfintech.com. 11. The shareholders may contact the undersigned or KFintech for any grievances connected with electronic voting: Mr. Rakesh R. Kalbate Mr. Raghunath Veedha, Company Secretary & Compliance Officer Deputy Manager-Corporate Registry Krebs Boichemicals & Industries Limited KFin Technologies Limited Kothapalli (V) Kasimkota (M), Anakapalli Selenium Tower B, Plot Nos. 31 & 32, (D), Vishakapatnam, Andhra Pradesh – Gachibowli, Financial District, 531031. Nanakramguda, Serilingampally, Tel: +91 -40-66808040 Hyderabad — 500 032. Email Id: com_sec@krebsbiochem.com Tel: +91-40-67162222, e-mail id: raghu.veedha@kfintech.com Kindly take this information on record. Thanking you, Yours Faithfully For Krebs Biochemicals & Industries Limited Rakesh R Kalbate Company Secretary & Compliance Officer ACS 66666 Regd. Office : Kothapalli (V), Kasimkota (M), Anakapalli, Visakhapatnam, Andhra Pradesh-531 031 Tel : 040-66808040 Website- www.krebsbiochem.com E-mail- com_sec@krebsbiochem.com Annual Report 2 0 2 5 - 2 6 Krebs Biochemicals & Industries Limited Five Years’ Highlight (` In Lakhs) Particluars 2021-22 2022-23 2023-24 2024-25 2025-26 Total Income 6,085.89 5,275.46 5,087.28 4,402.08 2,575.79 Profit / (Loss) Before Tax (4,452.68) (2,469.19) (1,972.84) (2,692.40) (1,693.31) Profit /(Loss) After Tax (4,452.68) (2,469.19) (1,972.84) (2,693.93) (1,693.31) Share Capital 2,156.06 2,156.06 2,156.06 2,156.06 2,156.06 Reserves & Surplus (9,665.38) (12,102.29) (14,077.73) (16,779.94) (18,431.53) Net Worth (7,509.32) (9,946.23) (11,921.67) (14,623.88) (16,275.47) Earnings Per Share (`) (20.81) (11.30) (9.16) (12.49) (7.85) Book Value Per Share (`) (34.83) (46.13) (55.29) (67.83) (75.49) CONTENTS Corporate Information 2 Notice 3 Directors’ Report 21 Secretarial Audit Report 30 Report on Corporate Governance 37 Management Discussion and Analysis 56 Independent Auditors’ Report 59 Balance Sheet 70 Statement of Profit and Loss 71 Cash Flow Statement 72 34th Annual Report 2025-26 Krebs Biochemicals & Industries Limited BOARD OF DIRECTORS REGISTERED OFFICE Dr. R T Ravi Krebs Biochemicals & Industries Limited Chairman / Non-Executive Director Kothapalli (V), Kasimkota (M), Anakapalli (D), (DIN - 00272977) Andhra Pradesh – 531031. Tel: +91 - 9121144984 Mr. Manish Kumar Jain Email : com_sec@krebsbiochem.com Managing Director & CEO Website: www.krebsbiochem.com (DIN - 06477976) CIN: L24110AP1991PLC103912 Mr. P K Bhattacharyya PLANT LOCATIONS Non-Executive Director (DIN - 07131152) Unit I: Regadichelika (V), Kodavalur (M), Nellore (D), Andhra Pradesh–524316. Mr. Avinash Ravi Non-Executive Director Unit II: Kothapalli (V), Kasimkota (M), Anakapalli, (DIN - 01616152) Vishakapatnam (D), Andhra Pradesh – 531031. Mr. P M Kathariya STATUTORY AUDITORS Independent Director M/s. Bhavani & Co. (DIN - 00281395) Chartered Accountants (FRN. 012139S) Ms. Dipti Shah Plot No. 48, Flat No. 201 , 2nd Floor, MICASA, Independent Director Phase - I, Kavuri Hills, Hyderabad – 500033. (DIN - 07995542) SECRETARIAL AUDITORS Mr. Satya Prakash Chigurupati DSMR & Associates Independent Director Company Secretaries, (DIN - 00721318) # 6-3-668/10/42, Plot No. 42, 2nd Floor, D [Showing first 8,000 characters — download PDF for full document]